|
1. |
ENHANCEMENT OF ALLOGRAFT SURVIVAL BY COMBINATION RS‐61443 AND DUP‐785 THERAPY |
|
Transplantation,
Volume 55,
Issue 4,
1993,
Page 691-694
TAKASHI KAWAMURA,
DEBRA HULLETT,
YASUYUKI SUZUKI,
WOLF BECHSTEIN,
ANTHONY ALLISON,
HANS SOLLINGER,
Preview
|
PDF (564KB)
|
|
摘要:
Current maintenance immunosuppressive therapy consists of cyclosporine in combination with prednisone and azathioprine. Unfortunately these agents are associated with significant side effects resulting in posttransplant morbidity and mortality. Therefore, the search for new immunosuppressive agents is essential, not only to improve the results after organ transplantation but equally important to reduce morbidity. Recently two new antiproliferative drugs, RS-61443 (RS) and DUP-785 (DUP), have become available. RS (my-cophenolate mefotil), a semisynthetic derivative of mycophenolic acid, inhibits purine de novo synthesis by noncompetitively and reversibly inhibiting inosine monophosphate dehydrogenase. DUP (brequinar sodium) inhibits pyrimidine synthesis by reversibly inhibiting dehydroorotate dehydrogenase. We evaluated subtherapeutic combination RS and DUP therapy in the rat (ACI→LEW) heterotopic heart allograft model. Median graft survival with no treatment, RS (20 mg/kg/day), DUP 3 mg/kg (3×/week), or DUP 6 mg/kg (3×/week) was 6.5, 11.5, 9.5 and 14.5, respectively. Median graft survival with combination therapy (RS 20 mg/kg, DUP 6 or 3 mg/kg 3×/week) was 133 days and 121 days, respectively. Furthermore, mean survival following cessation of all therapy at 100 days posttransplant was dramatically prolonged to 65.7±43.8 days in animals receiving combination therapy (RS 20 mg/kg/day, DUP 6 mg/kg 3×/week). Despite the potent immunosuppressive activity, recipients treated with combination therapy demonstrated no side effects and gained body weight during the treatment.To determine if low-dose combination therapy was effective in reversing ongoing rejection, treatment was delayed until the 5th postoperative day. Four of 5 recipients (80%) receiving RS monotherapy (60 mg/kg/day), 5 of 5 recipients (100%) receiving DUP monotherapy (12 mg/kg/day), and 4 of 5 grafts (80%) receiving combination therapy (RS 40 mg/kg/day and DUP 6 mg/kg/ day) survived over 21 days.Our results demonstrate that combination therapy significantly prolonged graft survival, and that the progression of advanced rejection was halted immediately. RS and DUP combination may provide a potent immunosuppressive therapy in clinical transplantation.
ISSN:0041-1337
出版商:OVID
年代:1993
数据来源: OVID
|
2. |
PROLONGATION OF CANINE INTESTINAL ALLOGRAFT SURVIVAL WITH RS‐61443, CYCLOSPORINE, AND PREDNISONE |
|
Transplantation,
Volume 55,
Issue 4,
1993,
Page 695-700
ANTHONY D'ALESSANDRO,
MARGARET RANKIN,
JOHN McVEY,
GHOLAM HAFEZ,
HANS SOLLINGER,
MUNCI KALAYOGLU,
FOLKERT BELZER,
Preview
|
PDF (928KB)
|
|
摘要:
The efficacy of RS-61443 and cyclosporine utilized either alone or in combination was assessed in both a segmental heterotopic and total orthotopic canine intestinal transplant model. Twenty-eight dogs underwent segmental (150-cm) heterotopic intestinal transplants and five dogs total orthotopic transplants. Five heterotopic groups were compared: group 1, no immunosuppression; group 2, cyclosporine and prednisone; group 3, RS-61443, cyclosporine and prednisone; group 4, RS-61443 and prednisone; and group 5, RS-61443 and subtherapeutic cyclosporine. Group 3 animals achieved a median survival of 136 days, while the median survivals of groups 1, 2, 4, and 5 were ≤10 days (P<.001). Twenty deaths in groups 1 through 5 were secondary to allograft rejection, two were due to infection, and two were unexplained. Four animals in group 3 were sacrificed, one at 83 days due to diarrhea and weight loss and three at the termination of the study. The median survival of five dogs undergoing total orthotopic transplantation (group 6) was 27.0 days and was significantly longer than groups 1, 4, and 5 (P<.01). No dog in this group had intestinal rejection—however, four were sacrificed due to weight loss and one died of malnutrition. The combination of RS-61443 and cyclosporine significantly prolonged intestinal allograft survival in both the heterotopic and orthotopic transplant models. Clinically, this combination may be promising for both combined liver-intestinal and isolated intestinal transplantation.
ISSN:0041-1337
出版商:OVID
年代:1993
数据来源: OVID
|
3. |
HAMSTER‐TO-RAT HEART AND LIVER XENOTRANSPLANTATION WITH FK506 PLUS ANTIPROLIFERATIVE DRUGS |
|
Transplantation,
Volume 55,
Issue 4,
1993,
Page 701-708
NORIKO MURASE,
THOMAS STARZL,
ANTHONY DEMETRIS,
LUIS VALDIVIA,
MINORU TANABE,
DONALD CRAMER,
LEONARD MAKOWKA,
Preview
|
PDF (856KB)
|
|
摘要:
Heterotopic hamster hearts transplanted to unmodified LEW rats underwent humoral rejection in 3 days. Survival was prolonged to a median of 4 days with 2 mg/kg/day FK506. As monotherapy, 15 mg/kg/day cyclophosphamide greatly prolonged graft survival—far more than could be accomplished with RS-61443, brequinar (BQR), mizoribine, methotrexate, or deoxyspergualin. However, when FK506 treatment, which was ineffective alone, was combined with a short induction course (14 or 30 days) of subtherapeutic BQR, RS-61443, or cyclophosphamide, routine survival of heart xenografts was possible for as long as the daily FK506 was continued. In addition, a single large dose of 80 mg/ kg cyclophosphamide 10 days preoperatively allowed routine cardiac xenograft survival under FK506. The ability of these antimetabolites to unmask the therapeutic potential of FK506 correlated, although imperfectly, with the prevention of rises of preformed heterospecific cytotoxic antibodies immediately postoperatively. As an adjunct to FK506, azathioprine was of marginal value, whereas mizoribine, methotrexate, and deoxyspergualin (DSPG) were of intermediate efficacy.After orthotopic hepatic xenotransplantation, the perioperative survival of the liver with its well-known
ISSN:0041-1337
出版商:OVID
年代:1993
数据来源: OVID
|
4. |
PROLONGING DISCORDANT XENOGRAFT SURVIVAL WITH ANTICOMPLEMENT REAGENTS K76COOH AND FUT175 |
|
Transplantation,
Volume 55,
Issue 4,
1993,
Page 709-712
SHUJI MIYAGAWA,
RYOTA SMRAKURA,
GORO MATSUMIYA,
NORIHIDE FUKUSHIMA,
SEIZOH NAKATA,
HIKARU MATSUDA,
MISAKO MATSUMOTO,
HAJIME KITAMURA,
TSUKASA SEYA,
Preview
|
PDF (550KB)
|
|
摘要:
The guinea pig heart, when transplanted into the rat heterotopically, is rejected within 30 min via activation of the alternative complement pathway. Natural antibody does not contribute to rejection. This xenotransplantation model was used to assess the effect of anticomplement reagents on discordant xenograft survival. In vivo administration of K76COOH (K76) to rats induced only slight suppression of factors B and D and a marked decrease of C3, leading to the depression of ACH50(reflecting the potency of the alternative pathway). On the other hand, FUT175 (FUT) reduced C3 activity by about 80% and inhibited factor B activity nearly 100% <1 hr after the administration, but inhibited factor D activity only marginally. FUT abrogated ACH50for >6 hr. Of note, the xenograft beating time was prolonged ∼3 times by FUT but not by K76, suggesting that direct inhibition of plasma serine protease factor B results in the complete suppression of ACH50and graft survival. The administration of both K76 and FUT resulted in the longest graft survival, but the effects of these reagents were abolished by additional antigraft antibody. Anticomplement reagents that block factor B and C3 are therefore effective for prolongation of discordant xenograft survival when the graft rejection is associated with the complement alternative pathway.
ISSN:0041-1337
出版商:OVID
年代:1993
数据来源: OVID
|
5. |
TREATMENT OF SEVERE DIABETES MELLITUS FOR MORE THAN ONE YEAR USING A VASCULARIZED HYBRID ARTIFICIAL PANCREAS |
|
Transplantation,
Volume 55,
Issue 4,
1993,
Page 713-717
TAKASHI MAKI,
J. A. LODGE,
MAURO CARRETTA,
HIROKI OHZATO,
KERMIT BORLAND,
SUSAN SULLIVAN,
JAMES STARUK,
THOMAS MULLER,
BARRY SOLOMON,
WILLIAM CHICK,
ANTHONY MONACO,
Preview
|
PDF (815KB)
|
|
摘要:
We report the successful application of a hybrid artificial pancreas device for the treatment of severe diabetes mellitus induced by total pancreatectomy in two dogs. Control of the blood sugar was achieved for more than 1 year in these two animals without any immunosuppressive therapy. Although exogenous insulin was required during the latter part of the study period, removal of the devices resulted in a rapid increase in the fasting blood sugar levels and the exogenous insulin requirements (P<0.001 versus weeks 1–52 in both dogs). Metabolic studies, postexplant in vitro studies, and histologic analyses confirmed islet cell survival and insulin production by the devices. This hybrid artificial pancreas has a clear clinical potential for islet cell transplantation without immunosuppression.
ISSN:0041-1337
出版商:OVID
年代:1993
数据来源: OVID
|
6. |
ISLET ALLOGRAFT, ISLET XENOGRAFT, AND SKIN ALLOGRAFT SURVIVAL IN CD8 |
|
Transplantation,
Volume 55,
Issue 4,
1993,
Page 718-721
NIRAJ DESAI,
HAMID BASSIRI,
JAMES KIM,
BEVERLY ROLLER,
OLIVER SMITHIES,
CLYDE BARKER,
ALI NAJI,
JAMES MARKMANN,
Preview
|
PDF (576KB)
|
|
摘要:
Despite extensive study, the immunologic mechanisms mediating allograft rejection have not been completely defined. In the current study, we evaluated the T cell subsets important in islet allograft, skin allograft, and islet xenograft rejection using a genetically engineered line of mice deficient in β2-microglobulin expression. Because these mice lack cell surface MHC class I expression, they are deficient in T cells of the CD8 subset (class I-restricted cytotoxic T cells). Pancreatic islet allografts transplanted to CD8+T cell-deficient recipients showed prolonged survival compared with controls. No prolongation was observed in the survival of pancreatic islet xenografts or in the survival of skin allografts transplanted to the CD8+T cell-deficient hosts. We conclude that CD8+T cells play a prominent role in islet allograft, but not islet xenograft or skin allograft, rejection in mice.
ISSN:0041-1337
出版商:OVID
年代:1993
数据来源: OVID
|
7. |
NONHUMAN PRIMATE RESPONSES TO MURINE AND HUMANIZED OKT4A |
|
Transplantation,
Volume 55,
Issue 4,
1993,
Page 722-727
FRANCIS DELMONICO,
A. COSIMI,
TATSUO KAWAI,
DRUIE CAVENDER,
WOAN-HWA LEE,
LINDA JOLLIFFE,
ROBERT KNOWLES,
Preview
|
PDF (716KB)
|
|
摘要:
A nonhuman primate antimurine response (MAMA) has been observed in 17 cynomolgus renal allograft recipients of murine OKT 4A. Neither cyclosporine, nor total-lymphoid irradiation, nor donor bone marrow preparation inhibited this antixenogeneic response.In an attempt to alter the antimurine basis of the response, a humanized chimeric OKT4A (IgG4) containing the entire variable portion of the murine OKT4A and a humanized CDR grafted OKT4A mAb sharing only the Complementarity Determining Region from the murine OKT4A, were administered to 8 cynomolgus allograft recipients. MAMA was detected in each recipient.In contrast to sera from recipients of murine OKT4A, sera from recipients of humanized OKT4A displayed no reactivity to other murine mAbs. MAMA specificity did not assay constant (C) region differences between the murine and humanized mAb; however, C region homology in humans should preclude a human antimouse antibody (KAMA) to the Fc portion of a humanized mAb.Furthermore, cynomolgus recipient serum levels of the humanized OKT4A mAb were maintained (>1 μg/ ml) for a longer period than following treatment with murine OKT4A (murine <12 days versus between 12 and 24 days for the humanized).If the HAMA response to humanized mAb in future clinical trials, were to be predictably anti-idiotypic, then the opportunity for treatment with sequential mAbs of differing idiotypes would be retained. Moreover, these current studies also suggest that humanized construction may influence the duration of therapeutic mAb levels. Thus, anti-idiotypic reactivity may not be as consequential to the clinical administration of humanized mAb to allograft recipients.
ISSN:0041-1337
出版商:OVID
年代:1993
数据来源: OVID
|
8. |
LIVERS FROM FASTED RATS ACQUIRE RESISTANCE TO WARM AND COLD ISCHEMIA INJURY |
|
Transplantation,
Volume 55,
Issue 4,
1993,
Page 728-732
R. SUMIMOTO,
J. SOUTHARD,
F. BELZER,
Preview
|
PDF (547KB)
|
|
摘要:
Successful liver transplantation is dependent upon many factors, one of which is the quality of the donor organ. Previous studies have suggested that the donor nutritional status may affect the outcome of liver transplantation and starvation, due to prolonged stay in the intensive care unit, may adversely affect the liver. In this study we have used the orthotopic rat liver transplant model to measure how fasting the donor affects the outcome of liver transplantation. Rat livers were preserved with UW solution either at 37°C (warm ischemia for 45–60 min) or at 4°C (cold ischemia for 30 or 44 hr). After preservation the livers were orthotopically transplanted and survival (for 7 days) was measured, as well as liver functions 6 hr after transplantation. After 45 min of warm ischemia 50% (3 of 6) animals survived when the liver was obtained from a fed donor about 80% (4 of 5) survived when the liver was obtained from a three-day-fasted donor. After 60 min warm ischemia no animal survived (0 of 8, fed group). However, if the donor was fasted for 3 days 89% (8 of 9) of the animals survived for 7 days. Livers cold-stored for 30 hr were 50% viable (3 of 6) and fasting for 1–3 days did not affect this outcome. However, if the donor was fasted for 4 days 100% (9 of 9) survival was obtained. After 44-hr preservation only 29% (2/7) of the recipients survived for 7 days. If the donor was fasted for 4 days, survival increased to 83% (5/6). Liver functions, bile production, and serum enzymes were better in livers from the fasted rats than from the fed rats. Fasting caused a 95% decrease in liver glycogen content. Even with this low concentration of glycogen, liver viability (animal survival) after warm or cold ischemia was not affected, and livers with a low glycogen content were fully viable. Thus liver glycogen does not appear to be important in liver preservation. This study shows that fasting the donor does not cause injury to the liver after warm or cold ischemia. In fact, the livers appeared to be better able to tolerate ischemia when obtained from fasted rats. Thus donor nutritional status may be an important factor for outcome of liver transplantation. Livers from fasted donors may be capable of tolerating long-term preservation better than livers from fed donors.
ISSN:0041-1337
出版商:OVID
年代:1993
数据来源: OVID
|
9. |
ASSESSMENT OF PURINE METABOLISM IN HUMAN RENAL TRANSPLANTATION |
|
Transplantation,
Volume 55,
Issue 4,
1993,
Page 733-736
F. VlGUÉS,
S. AMBEOSIO,
E. FRANCO,
R. BARTRONS,
Preview
|
PDF (459KB)
|
|
摘要:
Cortical levels of nucleotides and their degradation products from 42 transplanted human kidneys have been studied. Biopsies were performed during renal harvesting just before cooling, at the end of cold storage, and following reinstallment of renal blood circulation. ATP levels fell, and AMP and degradation products (inosine monophosphate [IMP], inosine, adenosine, and hypoxanthine) increased during cold storage and returned to near-normal values 30 min after recirculation. The major degradation product found was hypoxanthine, indicating very poor xanthine oxidase activity in human kidneys. The sum of adenine nucleotides (ATP+ADP+AMP) did not significantly decrease after cold storage, but adenylate energy charge (ATP+1/2ADP/ ATP+ADP+AMP) was reduced to half, being recovered in implanted kidneys. The sum of adenine nucleotides was significantly reduced after implantation. The rate of acute tubular necrosis was higher in kidneys preserved for more than 30 hr. Kidneys with acute tubular necrosis had significantly lower levels of the total pool of adenine nucleotides at reperfusion, but there was no correlation between incidence of acute tubular necrosis and ATP or other metabolite levels in the kidneys before or during cold preservation.The success of human kidney transplantation does not seem to depend only on the pool of residual nucleotides at the end of cold storage but on other factors that determine the ability of the cell to recover a normal energy state after reper fusion.
ISSN:0041-1337
出版商:OVID
年代:1993
数据来源: OVID
|
10. |
A RAT FATTY LIVER TRANSPLANT MODEL |
|
Transplantation,
Volume 55,
Issue 4,
1993,
Page 737-741
KENICHI TERAMOTO,
JOHN BOWERS,
URMILA KHETTRY,
JOHN PALOMBO,
MELVIN CLOUSE,
Preview
|
PDF (617KB)
|
|
摘要:
A rat model of fatty liver transplantation has been developed to study primary nonfunction in fatty liver grafts. ACI rats were fed with a diet deficient in choline and methionine for 7, 14, 28, and 42 days. Fat content in the pretransplant livers was examined by gas chromatography and histology. The main constituent of the fatty droplets was determined to be triglyceride. The triglyceride concentration reached a maximum by day 14 and remained constant for an additional 28 days. Histology revealed an absence of necrosis in 14− and 28-day fatty livers but scattered hepatocytic necrosis and inflammation in 42-day fatty livers.After being given cold (UW stored, 4°C) or warm (37°C) ischemia, the fatty liver was orthotopically transplanted into normal ACI rats. The one-week survival of fatty liver grafts after 6, 12, 18, and 24 hr cold preservation was 5/5, 5/6, 3/8, 0/6 for 14-day fatty liver and 5/5, 4/6, 0/8, 0/6 for 42-day fatty livers. The survival of normal liver grafts was 5/5, 6/6, 5/9, 2/8, respectively. Increased survival rate was correlated wit the absence of hepatocytic necrosis. The survival after 15 and 30 min warm ischemia prior to transplant was 5/5, 2/6 for normal liver grafts and 4/7, 0/6 for 28-day fatty liver graft, respectively. Fatty livers were less resistant to damage induced by cold or warm ischemia.
ISSN:0041-1337
出版商:OVID
年代:1993
数据来源: OVID
|
|